[Spinocerebellar degeneration and neuropeptides].
作者信息
Matsuoka Y, Sakurai N
出版信息
Nihon Naika Gakkai Zasshi. 1989 Dec;78(12):1705-8.
PMID:2516527
Abstract
摘要
相似文献
1
[Spinocerebellar degeneration and neuropeptides].
Nihon Naika Gakkai Zasshi. 1989 Dec;78(12):1705-8.
2
[Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
Riv Neurol. 1989 Mar-Apr;59(2):83-8.
3
Spinocerebellar degeneration and neuropeptides.
Jpn J Med. 1989 Nov-Dec;28(6):791-3. doi: 10.2169/internalmedicine1962.28.791.
4
[Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
Rinsho Shinkeigaku. 1988 Jun;28(6):595-604.
5
Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
Tokai J Exp Clin Med. 1995 Dec;20(4-6):203-8.
6
[Alteration of CBF and CMRO2 and TRH effects on CBF in spinocerebellar degeneration. The positron emission tomography study].
Rinsho Shinkeigaku. 1988 May;28(5):563-8.
7
[Spinocerebellar degeneration].
Ryoikibetsu Shokogun Shirizu. 2003(40):272-4.
8
Bedside and electro-oculographic analysis of abnormal ocular movements in spinocerebellar degenerations: effects of thyrotropin-releasing hormone.
Neurology. 1988 Jan;38(1):110-4. doi: 10.1212/wnl.38.1.110.
9
Oral thyrotropin-releasing hormone treatment in inherited ataxias.
Clin Neuropharmacol. 1988 Dec;11(6):520-8. doi: 10.1097/00002826-198812000-00005.
10
[Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
Rinsho Shinkeigaku. 1997 Jul;37(7):587-94.
Zotero 插件